<DOC>
	<DOCNO>NCT01695798</DOCNO>
	<brief_summary>Chronic malnutrition associate lack effective gut immunity possible explanation see polio case among proportion child receive 7 dos OPV.Our propose idea evaluate IPV antigen give later life may act together boost humoral mucosal immunity child belong low-income background Karachi moderate severe chronic malnutrition ( height age Z score less -2SD ) . We also intend compare eIPV + OPV OPV non-malnourished infant 9 -12 month age . Thus , propose study combination two trial , study population stratify nutritional status , reference arm ( bOPV ) experimental arm ( bOPV plus IPV ) .</brief_summary>
	<brief_title>IPV Moderate Severe Chronic Malnourished 9-12 Month Old Children Karachi .</brief_title>
	<detailed_description>The development chronic malnutrition complex interplay multiple factor ; include genetic predisposition whole host environmental insult . In urban squatter peri-urban settlement environment Karachi Aga Khan University ( AKU ) establish surveillance program , half infant moderate severe chronic malnutrition ( height age Z score less -2 SD ) time 9 -12 month old . IPV advantage parenteral route , thereby bypass damage gut mucosa malnourish child . It also cause rare vaccine-associated paralysis . Its effectiveness depend stimulation serum ( blood ) neutralize antibody block spread poliovirus central nervous system . The main disadvantage preclude IPV use low-income country high cost , difficulty add another injectable vaccine EPI schedule 6 , 10 , 14 week , lack ability induce strong mucosal immune response therefore prevent enteral infection . Additionally , maternal antibody early age neutralize IPV quite effectively . However , median age polio Pakistan 15 month poliovirus type 1 18 month poliovirus type 3 , may feasible give single IPV dose old age , avoid effect maternal antibody boost immunity polio majority child enter risk period Pakistan . Enhanced potency IPV ( eIPV ) high antigen content yield great 90 % seropositivity 3 type one dose 100 % seropositivity two dos . Thus use eIPV combine OPV 9 - 12 month moderate severe chronically malnourished infant may provide improved seroconversion well stimulation mucosal immune response . Our propose idea evaluate IPV antigen give later life may act together boost humoral mucosal immunity child belong low-income background Karachi moderate severe chronic malnutrition ( height age Z score less -2SD ) . We also intend compare eIPV + OPV OPV non-malnourished infant 9 -12 month age . Thus , propose study combination two trial , study population stratify nutritional status , reference arm ( bOPV ) experimental arm ( bOPV plus IPV ) .</detailed_description>
	<mesh_term>Malnutrition</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Infant age 9 12 month age Resident study area last 3 month time enrolment Parent/guardian provide informed consent Infant already enrol polio intervention study . Infant find acutely ill time enrolment , require emergent medical care Infant moderate severe acute malnutrition , define low weight height ( 2z 3z score median WHO growth standard respectively ) . Refusal blood test Receipt supplementary dose OPV within 4 week first study visit Infant certain medical condition i.e. , cerebral palsy , syndromic infant , infant corticosteroids medical illness , thrombocytopenia ( contraindication intramuscular injection ) , malignancy infant primary immunodeficiency</criteria>
	<gender>All</gender>
	<minimum_age>9 Months</minimum_age>
	<maximum_age>12 Months</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>poliomyelitis</keyword>
	<keyword>oral polio vaccine</keyword>
	<keyword>OPV</keyword>
	<keyword>seroconversion</keyword>
	<keyword>mucosal immunity</keyword>
	<keyword>malnutrition</keyword>
	<keyword>IPV</keyword>
	<keyword>Inactivated polio vaccine</keyword>
	<keyword>Pakistan</keyword>
</DOC>